title: Sickling-induced binding of autologous IgG to erythrocytes heterozygous for sickle hemoglobin.
abstract: This study reports that sickling-induced increased autoantibody binding can be demonstrated in varying degrees for deoxygenated S/beta-thalassemic (2-fold) and hemoglobin-SC (1.2-fold) erythrocytes as compared with oxygenated paired samples. In contrast, HbAS erythrocytes deoxygenated in autologous plasma exhibited less than 2% morphologic sickling and no increased IgG binding as compared with control samples. Sickling in the presence or absence of plasma increased the IgG binding capacity of S/beta-thalassemic erythrocytes, comparable to previous findings for HbSS erythrocytes, while increased IgG binding to HbSC erythrocytes was detected only after deoxygenation in plasma. It is concluded that specific IgG binding to deoxygenated S/beta-thalassemic RBCs results from subtle permanent sickling-induced alterations of the membrane surface, while IgG binding to HbSC erythrocytes sickled in plasma results from transitory membrane changes. These findings suggest that sickling in vivo will produce cumulative autoantibody binding to S/beta-thalassemic erythrocytes, a process which could lead to immune-mediated erythrocyte destruction. In contrast, comparatively small fractions of the autoantibody bound to HbSC erythrocytes in vivo would result from sickling-induced membrane alterations. These studies indicate that sickling-associated autoantibody binding in vivo will not occur for sickle cell trait (HbAS) erythrocytes protected by plasma.
authors.affiliation: USC School of Medicine, Department of Medicine, Los Angeles 90033.
authors.forename: G A
authors.initials: GA
authors.lastname: Green
mesh_terms: D000755:Anemia, Sickle Cell / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D001666:Binding Sites, Antibody; D004913:Erythrocytes, Abnormal / Q000276:immunology*; D006450:Hemoglobin SC Disease / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism*; D010949:Plasma; D012805:Sickle Cell Trait / Q000150:complications / Q000276:immunology*; D013789:Thalassemia / Q000150:complications / Q000276:immunology
chemical_list: D001323:Autoantibodies; D007074:Immunoglobulin G